Prescription Medicine
Prescription Medicine Brands
We have a reputation for providing effective products for the treatment of chronic obstructive pulmonary disease (COPD), heart attack, secondary stroke prevention and treatment, high blood pressure, thromboembolic disease, HIV/AIDS, Parkinson's disease, arthritis and pain relief in cancer.
Product Name
Generic Name
- Patient information leaflet
- Summary of product characteristics
- For more information email Medical Information
or call +44 (0) 1344 424600
- Patient information leaflet
- Summary of product characteristics
- For more information email Medical Information
or call +44 (0) 1344 424600
- For more information email Medical Information
or call +44 (0) 1344 424600
- Patient information leaflet
- Summary of product characteristics
- For more information email Medical Information
or call +44 (0) 1344 424600
- Patient information leaflet (Inhaler CFC-Free)
- Patient information leaflet (UDVs 1mL)
- Patient information leaflet (UDVs 2mL)
- Patient information leaflet (Aerocaps)
- Summary of product characteristics (Inhaler CFC-Free)
- Summary of product characteristics (UDVs)
- Summary of product characteristics (Aerocaps)
- For more information email Medical Information
or call +44 (0) 1344 424600
- Patient information leaflet
- Summary of product characteristics
- For more information email Medical Information
or call +44 (0) 1344 424600
- Patient information leaflet
- Summary of product characteristics
- For more information email Medical Information
or call +44 (0) 1344 424600
- Patient information leaflet (Ampoules)
- Patient information leaflet (Tablets)
- Summary of product characteristics (Ampoules)
- Summary of product characteristics (100mcg tablets)
- Summary of product characteristics (300mcg tablets)
- For more information email Medical Information
or call +44 (0) 1344 424600
- Patient information leaflet (UDVs)
- Summary of product characteristics (UDVs)
- For more information email Medical Information
or call +44 (0) 1344 424600
- Patient information leaflet
- Summary of product characteristics
- For more information email Medical Information
or call +44 (0) 1344 424600
- Patient information leaflet
- Summary of product characteristics
- For more information email Medical Information
or call +44 (0) 1344 424600
- Patient information leaflet
- Summary of product characteristics
- For more information email Medical Information
or call +44 (0) 1344 424600
- Patient information leaflet (10,000 units)
- Patient information leaflet (8,000 units)
- Summary of product characteristics
- For more information email Medical Information
or call +44 (0) 1344 424600
- Patient information leaflet (20mg tablets)
- Patient information leaflet (40mg tablets)
- Patient information leaflet (80mg tablets)
- Summary of product characteristics (20mg, 40mg and 80mg tablets)
- For more information email Medical Information
or call +44 (0) 1344 424600
- Patient information leaflet (40/12.5mg tablets)
- Patient information leaflet (80 mg/25 mg tablets)
- Patient information leaflet (80/12.5mg tablets)
- Summary of product characteristics (40/12.5 mg tablets and 80/12.5 mg tablets)
- Summary of product characteristics (80 mg/25 mg Tablets)
- For more information email Medical Information
or call +44 (0) 1344 424600
- Patient information leaflet (0.088mg tablets)
- Patient information leaflet (0.18mg tablets)
- Patient information leaflet (0.35mg tablets)
- Patient information leaflet (0.7mg tablets)
- Summary of product characteristics (0.088mg tablets)
- Summary of product characteristics (0.18mg tablets)
- Summary of product characteristics (0.35mg tablets)
- Summary of product characteristics (0.7mg tablets)
- Summary of product characteristics (0.26mg prolonged release tablets)
- Summary of product characteristics (0.52mg prolonged release tablets)
- Summary of product characteristics (1.05mg prolonged release tablets)
- Summary of product characteristics (2.1mg prolonged release tablets)
- Summary of product characteristics (3.15mg prolonged release tablets)
- Patient information leaflet (Prolonged release tablets)
- For more information email Medical Information
or call +44 (0) 1344 424600
- Patient information leaflet (7.5mg suppositories)
- Patient information leaflet (15mg suppositories)
- Patient information leaflet (7.5mg tablets)
- Patient information leaflet (15mg tablets)
- Summary of product characteristics (7.5mg suppositories)
- Summary of product characteristics (15mg suppositories)
- Summary of product characteristics (7.5mg tablets)
- Summary of product characteristics (15mg tablets)
- For more information email Medical Information
or call +44 (0) 1344 424600
- Patient information leaflet (2mg and 4mg tablets)
- Summary of product characteristics (2mg tablets)
- Summary of product characteristics (4mg tablets)
- For more information email Medical Information
or call +44 (0) 1344 424600
- Patient information leaflet (Concentrated oral solution)
- Patient information leaflet (Oral solution)
- Summary of product characteristics (Concentrated oral solution)
- Summary of product characteristics (Oral solution)
- For more information email Medical Information
or call +44 (0) 1344 424600
- Patient information leaflet (Ampoules)
- Patient information leaflet (25mg and 100mg tablets)
- Patient information leaflet (Retard)
- Summary of product characteristics (Ampoules)
- Summary of product characteristics (25mg tablets)
- Summary of product characteristics (100mg tablets)
- Summary of product characteristics (Retard)
- For more information email Medical Information
or call +44 (0) 1344 424600
- Summary of product characteristics (150mg hard capsules)
- Summary of product characteristics (110mg hard capsules)
- Summary of product characteristics (75mg hard capsules)
- Patient information leaflet
- Patient information leaflet (150mg hard capsules)
- Patient information leaflet (110mg hard capsules)
- Patient information leaflet (75mg hard capsules)
- For more information email Medical Information
For ▼ Pradaxa® (dabigatran etexilate) information enquiries please call 0845 601 7880
- Patient information leaflet
- Summary of product characteristics
- For more information email Medical Information
or call +44 (0) 1344 424600
- Patient information leaflet
- Summary of product characteristics
- For more information email Medical Information
or call +44 (0) 1344 424600
- Patient information leaflet (2.5mg solution for inhalation)
- Summary of product characteristics (2.5mg solution for inhalation)
- For more information email Medical Information
or call +44 (0) 1344 424600
- Patient information leaflet
- Summary of product characteristics
- For more information email Medical Information
or call +44 (0) 1344 424600
- Summary of Product Characteristics (400mg prolonged release tablets)
- Summary of Product Characteristics (200mg tablets)
- Summary of Product Characteristics (100mg prolonged release tablets)
- Summary of Product Characteristics (50mg prolonged release tablets)
- Summary of Product Characteristics (50mg/5ml oral suspension)
- Patient Information Leaflet (400mg prolonged release tablets)
- Patient Information Leaflet (200mg tablets)
- Patient Information Leaflet (50mg and 100mg prolonged release tablets)
- Patient Information Leaflet (50mg/5ml oral suspension)
- For more information email Medical Information
or call +44 (0) 1344 424600